| Michael Amoroso |
Michael Amoroso is currently the President, Chief Executive Officer & Director at Precision BioSciences, Inc. He is also the Chairman at Abeona Therapeutics, Inc. Previously, he worked as the SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. Michael completed his undergraduate degree at Rider University and holds an MBA from The Leonard N Stern School of Business. |
| Brian Kevany |
Brian Kevany is currently working as the CTO, Chief Scientific Officer & SVP at Abeona Therapeutics, Inc. He has an undergraduate degree from Michigan State University and a doctorate degree from the University of Florida. |
| Joseph Vazzano |
Joseph Vazzano is an Independent Director at Allarity Therapeutics A. He is also an Independent Director at Allarity Therapeutics, Inc. and the Chief Financial & Accounting Officer at Abeona Therapeutics, Inc. Mr. Vazzano previously worked as an Assistant Corporate Controller at Intercept Pharmaceuticals, Inc. and as a Senior Auditor at KPMG LLP. He also served as an Assistant Controller at Pernix Therapeutics, Inc. and as the Chief Financial Officer & Secretary at Avenue Therapeutics, Inc. Mr. Vazzano obtained his undergraduate degree from Lehigh University. |
| Amanda Moore |
Amanda Moore is currently working as the VP-Program Leadership & Clinical Development at Abeona Therapeutics, Inc. She completed her graduate degree at George Washington University. |
| Madhav Vasanthavada |
Madhav Vasanthavada is currently the Chief Commercial Officer & Senior Vice President at Abeona Therapeutics, Inc. He holds a doctorate degree from the University of Rhode Island, an undergraduate degree from Osmania University, and an MBA from Harvard Business School. |
| Igor Grachev |
Igor Grachev is currently the Chief Medical Officer at Abeona Therapeutics, Inc. He is also a member of the Society For Neuroscience, The American Society for Clinical Pharmacology & Therapeutics, and the Society of Nuclear Medicine & Molecular Imaging. Previously, he was the VP-Business Development & Clinical Affairs at BioClinica, Inc. and the Vice President-Clinical Development at Marinus Pharmaceuticals, Inc. He also briefly served as the Chief Medical Officer at Cellectar Biosciences, Inc. in 2020. Dr. Grachev holds doctorate degrees from both the National Medical University and the National Medical Academy of Post-Graduate Education. |
| Vishwas Seshadri |
Vishwas Seshadri is currently the President, Chief Executive Officer, COO & Director at Abeona Therapeutics, Inc. He previously worked as an Executive Director at Bristol Myers Squibb Co. from 2020 to 2021. Prior to that, he held a position as the Head-Early Stage Upstream Process Development at Dr. Reddy's Laboratories, Inc. Dr. Seshadri holds a doctorate degree from the University of Arizona and an MBA from The Wharton School of the University of Pennsylvania. |
| Donald A. Wuchterl |
Donald A. Wuchterl is an Independent Director at Abeona Therapeutics, Inc. and Senior VP & Chief Manufacturing Officer at T-Knife Therapeutics, Inc. He was previously the Chief Operating Officer & Senior Vice President at Cytovance Biologics, Inc. and Senior VP-Technical Operations & Quality at Astellas Gene Therapies, Inc. He holds an undergraduate degree from Colorado Technical University, Inc. and an MBA from Fitchburg State University. |
| Christine Berni Silverstein |
Christine Berni Silverstein is currently an Independent Director at Abeona Therapeutics, Inc. and Marinus Pharmaceuticals, Inc. She is also a Member of the National Investor Relations Institute, Women in Bio, Inc., and Project 1972, Inc. In the past, she worked as a Managing Director at SCO Financial Group LLC and as a Director-Investor Relations at Relmada Therapeutics, Inc. She also served as the Chief Financial Officer at Emendo Biotherapeutics, Inc. Ms. Silverstein obtained her undergraduate degree from the Peter J. Tobin College of Business. |
| Mark J. Alvino |
Mark J. Alvino is the founder of Bridge Back Foundation. He is currently an Independent Director at Abeona Therapeutics, Inc., Director of Business Development at Navitas Pharma, Inc., Director at PainQx, Inc., and President at Hudson Square Capital LLC. Previously, he served as a Director at MacroChem Corp., Independent Director at Abeona Therapeutics, Inc., Managing Director at SCO Capital Partners LLC, Managing Director at Griffin Securities, Inc., and Managing Director at SCO Financial Group LLC. He also held positions as Vice President-Investor Relations at Allen & Caron, Inc. and Senior VP-Investor & Corporate Communications at Feinstein Kean Healthcare. Alvino received his undergraduate degree from George Washington University and Moravian College. |
| Faith L. Charles |
Faith L. Charles is the founder of Women in Bio, Inc. She currently holds multiple positions including Chairman of Life Sciences Group at Thompson Hine LLP, Chairman at CNS Pharmaceuticals, Inc., Independent Director at Abeona Therapeutics, Inc., Director at Agilvax, Inc., Director at Amydis, Inc., Independent Director at Avenue Therapeutics, Inc., and Independent Director at Conduit Pharmaceuticals, Inc. She previously held positions as Director at Gilda's Club New York City, Inc., Director at Sandstone Diagnostics, Inc., and Partner at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC. She received her undergraduate degree from Barnard College and her graduate degree from George Washington University Law School. |
| Leila Alland |
Leila Alland is an Independent Director at Abeona Therapeutics, Inc., a Director at Jubilant Therapeutics, Inc., and a Non-Executive Director at Radiopharm Theranostics Ltd. She previously worked as a Director at Cytovia Therapeutics, Inc., Chief Medical Officer at Affimed NV, Vice President & Head-Oncology at AstraZeneca LP, and Chief Medical Officer at Tarveda Therapeutics, Inc. She also held the position of Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. and Chief Medical Officer at PMV Pharmaceuticals, Inc. Alland received her undergraduate degree from the University of Pennsylvania and her doctorate from New York University School of Medicine. |
